Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case-control study

BACKGROUND: Obesity has a large prevalence among HIV-infected patients. Increased adipose tissue mass affects the pharmacokinetics of numerous drugs, but only a few data are available for antiretroviral drugs. OBJECTIVE: In this study, we aimed to explore the pharmacokinetics of antiretroviral drugs...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Antimicrob Chemother
Autori principali: Madelain, Vincent, Le, Minh, Champenois, Karen, Charpentier, Charlotte, Landman, Roland, Joly, Veronique, Yeni, Patrick, Descamps, Diane, Yazdanpanah, Yazdan, Peytavin, Gilles
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2017
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5517629/
https://ncbi.nlm.nih.gov/pubmed/28065890
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkw527
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi